Tabalumab (LY2127399) is a human monoclonal antibody of the IgG4 subtype designed to specifically target and neutralize both membrane-bound and soluble forms of B-cell activating factor (BAFF). This antibody exhibits potent neutralizing activity, making it a valuable tool for research into autoimmune disorders including rheumatoid arthritis, renal failure, and systemic lupus erythematosus. Tabalumab's specificity and efficacy in modulating BAFF-mediated processes provide a critical resource for investigating the pathophysiology and potential therapeutic interventions for these conditions.
Tabalumab (LY2127399) is a human monoclonal antibody of the IgG4 subtype designed to specifically target and neutralize both membrane-bound and soluble forms of B-cell activating factor (BAFF). This antibody exhibits potent neutralizing activity, making it a valuable tool for research into autoimmune disorders including rheumatoid arthritis, renal failure, and systemic lupus erythematosus. Tabalumab's specificity and efficacy in modulating BAFF-mediated processes provide a critical resource for investigating the pathophysiology and potential therapeutic interventions for these conditions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
